GLP-compliant peptide testing with IND/DMF-ready CoA. Validated methods. Expert review on every order.
Reverse-phase HPLC/UHPLC purity quantification with impurity profiling to sub-0.1% detection, calibrated to USP/ICH specifications.
High-resolution ESI-MS and MALDI-TOF for sequence confirmation, PTM detection, disulfide mapping, and structural verification.
Accelerated and real-time stability programs — complete data packages for IND and CMC submissions.
USP <71> sterility testing and LAL-based endotoxin / BET detection for injectable-grade peptides.
Quantitative amino acid composition confirming sequence integrity and chiral purity assessment.
Methods for cyclic, stapled, PEGylated, phosphorylated, glycosylated, and D-amino acid peptides.
Peptide testing is the analytical characterization of synthetic peptides to confirm purity, identity, sequence, potency, and safety. A peptide testing lab uses HPLC for purity, mass spectrometry (ESI-MS or MALDI-TOF) for identity, amino acid analysis for composition, and sterility/endotoxin assays for injectable-grade material.
Apollo Analytical measures peptide purity by RP-HPLC/UHPLC to sub-0.1% impurity detection, confirms identity by ESI-MS and MS/MS sequencing, quantifies composition by amino acid analysis (AAA), and runs USP <71> sterility plus LAL endotoxin testing for injectable peptides.
Standard peptide testing turnaround at Apollo Analytical is 5 business days or less for most tests from sample receipt. Rush programs are available. Every peptide testing report ships with a signed Certificate of Analysis (CoA) suitable for IND/CMC documentation.
Yes. Apollo Analytical operates GLP-compliant peptide testing methodology aligned with ICH Q1A, Q1B, Q3A and USP <71>. CoAs are scientist-reviewed and signed before release.
Yes — our peptide testing lab handles cyclic, stapled, PEGylated, phosphorylated, glycosylated, and D-amino acid peptides with method development tailored to non-standard chemistries.
Biopharma research groups, compounding pharmacies, and contract manufacturers rely on Apollo Analytical for release-grade peptide data.